PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:28 AM ET

Sponsor Check › Person

PM
No photo found yet (own website and image search run after this page is viewed)

Patrick McGoldrick

Named as an officer, director or promoter on SEC Form D filings · NY · May 11, 2022 → Sep 29, 2026

11deals (issuers)
$1.1Breported sold
273investors
17Form D filings
2022–2026years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:52 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Patrick McGoldrick is listed as an executive officer on 17 SEC Form D filings by 11 issuers between May 2022 and Sep 2026. Largest by amount reported sold: 270 Growth Fund I LP (New York, NY — pooled investment fund — 2022–2023; $454.7M reported sold to 162 investors), 270 Growth Fund I (Lux) SCSp-RAIF (Grand Duchy of Luxembourg, Luxembourg (as filed: N4) — pooled investment fund — 2022–2023; $413.8M reported sold to 66 investors), 270 Healthcare Growth Fund I LP (New York, NY — pooled investment fund — 2025–2026; $113.9M reported sold to 27 investors), 270 Healthcare Growth Fund I (LUX) SCSp-RAIF (Luxembourg, Luxembourg (as filed: N4) — pooled investment fund — 2025–2026; $113.9M reported sold to 18 investors), 270 Hybrid Growth Onshore Fund, LP (New York, NY — pooled investment fund — 2026) and 6 more (all listed below).

What this means That is a lot of deals — 11 separate companies raised money with this person listed as executive officer, over about 4 years. Across those companies the filings report $1.1B sold in total.

Listed alongside Samantha Beattie (17 shared filings), Gaurav Gupta (9 shared filings), Stephen Squinto (9 shared filings), Anya Schiess (7 shared filings), Brian Carlin (6 shared filings) and 15 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Patrick. Each name links to their own page.

All 11 issuers belong to the sponsor group J P Morgan (681 issuers, $310.46B reported sold, 2008–2026).

What this means A sponsor group is one team that sets up a new company for each deal. J P Morgan has 681 companies on file and $310.46B reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 5 bankruptcy cases matching the name listed in Key records below.

What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 17 public filings for Patrick McGoldrick and found 5 differences, 1 worth asking the sponsor about: 4 paid sellers are listed without a CRD number; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Patrick McGoldrick has not run yet — it is joining a line of 16,848 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:52 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Patrick McGoldrick..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

5 cases: 5 closed (disposition not in docket feed)

Patrick M. McGoldrick closed
United States Bankruptcy Court, D. Connecticut · No. 21-21119 · Filed Dec 14, 2021 · Closed Mar 31, 2022
Role of Patrick M. McGoldrick: Debtor · Outcome: Case closed 2022-03-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 6 federal dockets); court in CT (not a filing state)
Patrick C McGoldrick and Cathy A McGoldrick closed
United States Bankruptcy Court, M.D. Pennsylvania · No. 5:07-bk-52480 · Filed Sep 26, 2007 · Closed Feb 20, 2008
Role of Patrick C McGoldrick and Cathy A McGoldrick: Debtor · Outcome: Case closed 2008-02-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 6 federal dockets); court in PA (not a filing state)
Patrick F. McGoldrick closed
United States Bankruptcy Court, W.D. Oklahoma · No. 06-13571 · Filed Dec 31, 2006 · Closed Aug 16, 2011
Role of Patrick F. McGoldrick: Debtor · Outcome: Case closed 2011-08-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 6 federal dockets); court in OK (not a filing state)
Patrick McGoldrick and Amanda McGoldrick closed
United States Bankruptcy Court, W.D. Oklahoma · No. 05-24932 · Filed Oct 11, 2005 · Closed Mar 20, 2006
Role of Patrick McGoldrick and Amanda McGoldrick: Debtor · Outcome: Case closed 2006-03-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 6 federal dockets); court in OK (not a filing state)
Patrick M. McGoldrick closed
United States Bankruptcy Court, D. Connecticut · No. 94-22745 · Filed Aug 1, 1994 · Closed Nov 18, 1994
Role of Patrick M. McGoldrick: Debtor · Outcome: Case closed 1994-11-18 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 6 federal dockets); court in CT (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:52 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

5 differences found between the filings for Patrick McGoldrick — 1 worth asking about (compared 17 filings on Oct 24, 2026)

Worth asking · Sep 5, 2023 – Nov 13, 2023

4 paid sellers are listed without a CRD number

Paid seller listed without a CRD number: JPMORGAN ASSET MANAGEMENT (JAPAN) LIMITED — 270 Life Sciences Private Capital Employee Fund I LP · Paid seller listed without a CRD number: JPMORGAN ASSET MANAGEMENT (UK) LIMITED — 270 Life Sciences Private Capital Employee Fund I LP · Paid seller listed without a CRD number: JPMorgan Asset Management (Japan) Limited — 270 Life Sciences Private Capital Fund I LP · Paid seller listed without a CRD number: JPMorgan Asset Management (Japan) Limited — 270 Life Sciences Private Capital Fund I (Lux) SCSp-RAIF

What this means Without a CRD number we cannot look a seller up on BrokerCheck. Ask who they are and whether they are registered.

Sources
Note · Apr 5, 2022 – May 11, 2022

Form D filed 36 days after the first sale — 270 Growth Fund I LP

The filing says the first sale was Apr 5, 2022. The Form D was filed May 11, 2022 — 36 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 21 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Apr 5, 2022 – May 11, 2022

Form D filed 36 days after the first sale — 270 Growth Fund I (Lux) SCSp-RAIF

The filing says the first sale was Apr 5, 2022. The Form D was filed May 11, 2022 — 36 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 21 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · May 11, 2022 – Apr 12, 2023

Offering amount lowered between filings — 270 Growth Fund I LP

The May 11, 2022 filing says $1,000,000,000 offered; the Apr 12, 2023 Form D/A says $454,700,000.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Sources
Note · May 11, 2022 – Apr 12, 2023

Offering amount lowered between filings — 270 Growth Fund I (Lux) SCSp-RAIF

The May 11, 2022 filing says $1,000,000,000 offered; the Apr 12, 2023 Form D/A says $413,800,000.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 11 offerings report sales commissions totalling $5,387,273; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Sep 29, 2026 D/A
270 Healthcare Growth Fund I LP
File 021-559127
$0 (est.)$0 (est.)$0 (est.)
The special limited partner is entitled to carried interest. The investment manager is entitled to a management fee. The carried interest and management fee are fully discussed in the Issuer's confidential offering materials.
J.P. Morgan Institutional Investments Inc. BrokerCheck CRD 102920 ↗
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
EDGAR ↗
Sep 29, 2026 D/A
270 Healthcare Growth Fund I (LUX) SCSp-RAIF
File 021-559129
$0 (est.)$0 (est.)$0 (est.)
The special shareholder is entitled to carried interest. The investment manager is entitled to a management fee. The carried interest and management fee are fully discussed in the Issuer's confidential offering materials.
J.P. Morgan Institutional Investments Inc. BrokerCheck CRD 102920 ↗
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
EDGAR ↗
Sep 16, 2026 D
270 Hybrid Growth Onshore Fund, LP
File 021-597752
$0 (est.)$0 (est.)$0 (est.)
The special limited partner is entitled to a performance allocation and the investment advisor is entitled to a management fee, each of which is discussed in the Issuer's confidential offering materials.
J.P. Morgan Institutional Investments Inc. BrokerCheck CRD 102920 ↗
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
EDGAR ↗
Sep 16, 2026 D
270 Life Sciences Private Capital Fund II (US) LP
File 021-597633
$0 (est.)$0 (est.)$0 (est.)
The special limited partner is entitled to carried interest. The investment manager is entitled to a management fee. The carried interest and management fee are fully discussed in the Issuer's confidential offering materials.
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
J.P. Morgan Institutional Investments Inc. BrokerCheck CRD 102920 ↗
EDGAR ↗
Sep 16, 2026 D
270 Life Sciences Private Capital Fund II (Cayman) LP
File 021-597634
$0 (est.)$0 (est.)$0 (est.)
The special limited partner is entitled to carried interest. The investment manager is entitled to a management fee. The carried interest and management fee are fully discussed in the Issuer's confidential offering materials.
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
J.P. Morgan Institutional Investments Inc. BrokerCheck CRD 102920 ↗
EDGAR ↗
Sep 16, 2026 D
270 Hybrid Growth Cayman Fund, LP
File 021-597751
$0 (est.)$0 (est.)$0 (est.)
The special limited partner is entitled to a performance allocation and the investment advisor is entitled to a management fee, each of which is discussed in the Issuer's confidential offering materials.
J.P. Morgan Institutional Investments Inc. BrokerCheck CRD 102920 ↗
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
EDGAR ↗
Nov 13, 2023 D
270 Life Sciences Private Capital Employee Fund I LP
File 021-496947
$0 (est.)$0 (est.)$0 (est.)
The special limited partner is entitled to carried interest. The investment manager is entitled to a management fee. The carried interest and management fee are fully discussed in the Issuer's confidential offering materials.
J.P. MORGAN INSTITUTIONAL INVESTMENTS INC. BrokerCheck CRD 102920 ↗
JPMORGAN ASSET MANAGEMENT (JAPAN) LIMITED no CRD number reported
JPMORGAN ASSET MANAGEMENT (EUROPE) S.A.R.L. BrokerCheck CRD 304190 ↗
JPMORGAN ASSET MANAGEMENT (UK) LIMITED no CRD number reported
EDGAR ↗
Sep 5, 2023 D
270 Life Sciences Private Capital Fund I LP
File 021-491365
$0 (est.)$0 (est.)$0 (est.)
The special limited partner is entitled to carried interest. The investment manager is entitled to a management fee. The carried interest and management fee are fully discussed in the Issuer's confidential offering materials.
J.P. Morgan Institutional Investments Inc. BrokerCheck CRD 102920 ↗
JPMorgan Asset Management (UK) Limited BrokerCheck CRD 135960 ↗
JPMorgan Asset Management (Japan) Limited no CRD number reported
JPMorgan Asset Management (Europe) S.a r.l. BrokerCheck CRD 304190 ↗
EDGAR ↗
Sep 5, 2023 D
270 Life Sciences Private Capital Fund I (Lux) SCSp-RAIF
File 021-491366
$0 (est.)$0 (est.)$0 (est.)
The special shareholder is entitled to carried interest. The investment manager is entitled to a management fee. The carried interest and management fee are fully discussed in the Issuer's confidential offering materials.
J.P. Morgan Institutional Investments Inc. BrokerCheck CRD 102920 ↗
JPMorgan Asset Management (UK) Limited BrokerCheck CRD 135960 ↗
JPMorgan Asset Management (Japan) Limited no CRD number reported
JPMorgan Asset Management (Europe) S.a r.l. BrokerCheck CRD 304190 ↗
EDGAR ↗
May 4, 2023 D/A
270 Growth Fund I (Lux) SCSp-RAIF
File 021-445287
$2,980,650 (est.)$0$0N/A no CRD number reported
via "J.P. Morgan Securities LLC (""JPM"")" (CRD 79 ↗)
EDGAR ↗
May 4, 2023 D/A
270 Growth Fund I LP
File 021-445234
$2,406,623 (est.)$0$0N/A no CRD number reported
via "J.P. Morgan Securities LLC (""JPM"")" (CRD 79 ↗)
EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 11

Every issuer that named Patrick McGoldrick on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Pooled Investment Fund · group: J P Morgan

270 Healthcare Growth Fund I LP

New York, NY · Sep 29, 2025 → Sep 29, 2026 · 2 filings
  • Sep 29, 2026 · D/A · $113,926,000 sold of Indefinite · 27 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Sep 29, 2025 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $113.9M from 27 investors as of the latest filing. Patrick is listed as executive officer on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: J P Morgan

270 Healthcare Growth Fund I (LUX) SCSp-RAIF

Luxembourg, Luxembourg (as filed: N4) · Sep 29, 2025 → Sep 29, 2026 · 2 filings
  • Sep 29, 2026 · D/A · $113,926,000 sold of Indefinite · 18 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Sep 29, 2025 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $113.9M from 18 investors as of the latest filing. Patrick is listed as executive officer on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: J P Morgan

270 Hybrid Growth Onshore Fund, LP

New York, NY · Sep 16, 2026
  • Sep 16, 2026 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Patrick McGoldrick is a Managing Director of J.P. Morgan Investment Management Inc., the Investment Advisor to the Issuer.) EDGAR ↗

No sales reported yet as of the latest filing. Patrick is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: J P Morgan

270 Hybrid Growth Cayman Fund, LP

New York, NY · Sep 16, 2026
  • Sep 16, 2026 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Patrick McGoldrick is a Managing Director of J.P. Morgan Investment Management Inc., the Investment Advisor to the Issuer.) EDGAR ↗

No sales reported yet as of the latest filing. Patrick is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: J P Morgan

270 Life Sciences Private Capital Fund II (Cayman) LP

New York, NY · Sep 16, 2026
  • Sep 16, 2026 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Patrick is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: J P Morgan

270 Life Sciences Private Capital Fund II (US) LP

New York, NY · Sep 16, 2026
  • Sep 16, 2026 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Patrick is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: J P Morgan

270 Life Sciences Private Capital Employee Fund I LP

New York, NY · Nov 13, 2023
  • Nov 13, 2023 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Patrick is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: J P Morgan

270 Life Sciences Private Capital Fund I (Lux) SCSp-RAIF

Luxembourg, Luxembourg (as filed: N4) · Sep 5, 2023
  • Sep 5, 2023 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Patrick is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: J P Morgan

270 Life Sciences Private Capital Fund I LP

New York, NY · Sep 5, 2023
  • Sep 5, 2023 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Patrick is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: J P Morgan

270 Growth Fund I (Lux) SCSp-RAIF

Grand Duchy of Luxembourg, Luxembourg (as filed: N4) · May 11, 2022 → May 4, 2023 · 3 filings
  • May 4, 2023 · D/A · $413,800,000 sold of $413,800,000 · 66 investors · min. $250,000 · role: Executive Officer EDGAR ↗
  • Apr 12, 2023 · D/A · $413,800,000 sold of $413,800,000 · 66 investors · min. $250,000 · role: Executive Officer EDGAR ↗
  • May 11, 2022 · D · $295,000,000 sold of $1,000,000,000 · 38 investors · min. $250,000 · role: Executive Officer EDGAR ↗

Raised $413.8M from 66 investors (100% of the $413.8M target) as of the latest filing. Patrick is listed as executive officer on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: J P Morgan

270 Growth Fund I LP

New York, NY · May 11, 2022 → May 4, 2023 · 3 filings
  • May 4, 2023 · D/A · $454,700,000 sold of $454,700,000 · 162 investors · min. $250,000 · role: Executive Officer EDGAR ↗
  • Apr 12, 2023 · D/A · $454,700,000 sold of $454,700,000 · 162 investors · min. $250,000 · role: Executive Officer EDGAR ↗
  • May 11, 2022 · D · $377,900,000 sold of $1,000,000,000 · 96 investors · min. $250,000 · role: Executive Officer EDGAR ↗

Raised $454.7M from 162 investors (100% of the $454.7M target) as of the latest filing. Patrick is listed as executive officer on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Patrick 20

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

Management entity

J. P. Morgan Investment Management Inc.

Executive Officer · 6 shared filings (2 issuers) · also on 113 other issuers

J. P. Morgan Investment Management Inc. is on 115 issuers in total — a repeat sponsor. Their page lists every one.

Management entity

JPMorgan Asset Management (Europe) S.a r.l.

Executive Officer · 3 shared filings (1 issuer) · also on 16 other issuers

JPMorgan Asset Management (Europe) S.a r.l. is on 17 issuers in total — a repeat sponsor. Their page lists every one.

Management entity

270 Growth Fund GP (Lux) S.a r.l.

Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Patrick McGoldrick. Their page shows their other deals.

Management entity

J.P. Morgan Growth Equity Partners

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Patrick McGoldrick. Their page shows their other deals.

Management entity

270 Growth Fund GP LLC

Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Patrick McGoldrick. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Samantha Beattie

Executive Officer · 17 shared filings (11 issuers) · also on 8 other issuers

Samantha Beattie is on 19 issuers in total — a repeat sponsor. Their page lists every one.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Squinto

Executive Officer · 9 shared filings (7 issuers) · also on 9 other issuers

Stephen Squinto is on 16 issuers in total — a repeat sponsor. Their page lists every one.

GG
No photo found yet (own website and image search run after this page is viewed)
Person

Gaurav Gupta

Executive Officer · 9 shared filings (7 issuers) · also on 1 other issuer

Gaurav Gupta is on 8 issuers in total — a repeat sponsor. Their page lists every one.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Anya Schiess

Executive Officer · 7 shared filings (5 issuers)

Anya Schiess is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Rick Smith

Executive Officer · 6 shared filings (2 issuers) · also on 18 other issuers

Rick Smith is on 20 issuers in total — a repeat sponsor. Their page lists every one.

CD
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Dawe

Executive Officer · 6 shared filings (2 issuers) · also on 4 other issuers

Christopher Dawe is on 6 issuers in total — a repeat sponsor. Their page lists every one.

LS
No photo found yet (own website and image search run after this page is viewed)
Person

Luke Sikora

Executive Officer · 6 shared filings (2 issuers)

Listed on the same filings as Patrick McGoldrick. Their page shows their other deals.

BC
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Carlin

Executive Officer · 6 shared filings (2 issuers)

Listed on the same filings as Patrick McGoldrick. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Siletto

Executive Officer · 4 shared filings (2 issuers)

Listed on the same filings as Patrick McGoldrick. Their page shows their other deals.

ES
No photo found yet (own website and image search run after this page is viewed)
Person

Evan Sotiriou

Executive Officer · 3 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Patrick McGoldrick. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Hardiman

Director · 2 shared filings (2 issuers) · also on 15 other issuers

Joseph Hardiman is on 17 issuers in total — a repeat sponsor. Their page lists every one.

PH
No photo found yet (own website and image search run after this page is viewed)
Person

Paris Heymann

Executive Officer · 2 shared filings (2 issuers)

Listed on the same filings as Patrick McGoldrick. Their page shows their other deals.

The team behind the deals

Sponsor group

J P Morgan

681 issuers · 1990 filings · $310.46B reported sold · 2008–2026

One team, 681 deal companies. Patrick McGoldrick is listed on 11 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Patrick McGoldrick.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

A person is never an adviser firm. 2 of the 11 issuers this person is listed on match a Form ADV adviser (searched 24,962 advisers as of Oct 2, 2026): 270 Growth Fund I (Lux) SCSp-RAIF, 270 Growth Fund I LP.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Patrick McGoldrick by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 11 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Patrick McGoldrick is listed on: none on file. No website or social profile named in 270 Growth Fund I LP's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #127,580 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (New York, NY). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Patrick McGoldrick appears on a new Form D, or when a court case or SEC action is matched to them. See plans →